A condition in which this substance is elevated in the blood can be caused by mutations in P-C-S-K-nine and commonly causes xanthelasma palpebrarum (ZAN-thuh-LASS-muh PAL-puh-BRAY-rum). In humans, the protein S-CAP detects low levels of this substance and binds to S-R-E-B-Ps to stimulate biosynthesis of this substance. Drugs used to inhibit the bio-synthesis of this substance are commonly given with co-enzyme Q-ten to prevent myopathy. In one disease that stems from the accumulation of this substance, macrophages called (*) "foam cells" form on blood vessel walls. I-P-P results from the decarb
A condition in which this substance is elevated in the blood can be caused by mutations in P-C-S-K-nine and commonly causes xanthelasma palpebrarum (ZAN-thuh-LASS-muh PAL-puh-BRAY-rum). In humans, the protein S-CAP detects low levels of this substance and binds to S-R-E-B-Ps to stimulate biosynthesis of this substance. Drugs used to inhibit the bio-synthesis of this substance are commonly given with co-enzyme Q-ten to prevent myopathy. In one disease that stems from the accumulation of this substance, macrophages called (*) "foam cells" form on blood vessel walls. I-P-P results from the decarboxylation of mevalonate (meh-VAL-oh-nate) in the biosynthesis of this substance; the rate limiting step of that biosynthesis is catalyzed by H-M-G-Co-A reductase, which is inhibited by statins. For 10 points, name this lipid used in animal cell membranes and as a precursor to steroid hormones.
A condition in which this substance is elevated in the blood can be caused by mutations in P-C-S-K-nine and commonly causes xanthelasma palpebrarum (ZAN-thuh-LASS-muh PAL-puh-BRAY-rum).
cholesterol [accept LDL or HDL; prompt on lipids or fats]